Who are ZyVersa Therapeutics, Inc.'s main suppliers?

ZyVersa Therapeutics, Inc. (ZVSA) key suppliers include: VARIANT-PHARMACEUTICALS-INC, VENDOR, Morgan Stanley, Morgan Stanley, ORANY and 1 more. View the full supplier network at chainsifter.com/chain/ZVSA.

Who are ZyVersa Therapeutics, Inc.'s major customers?

ZyVersa Therapeutics, Inc. (ZVSA) key customers include: Morgan Stanley, Morgan Stanley, ORANY, ORANY. View the full customer network at chainsifter.com/chain/ZVSA.

What sector is ZyVersa Therapeutics, Inc. in?

ZyVersa Therapeutics, Inc. (ZVSA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ZVSA Supply Chain: ZyVersa Therapeutics, Inc. Supplier List & 13 Relationships

6Suppliers

4Customers

3Debt Items

20Related Chains

ZyVersa Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
VARIANT-PHARMACEUTICALS-INC	VARIANT-PHARMACEUTICALS-INC	90%	Form of Warrant pursuant to License Agreement, dated December 15, 2015, by and between L&F Research LLC and Variant Pharmaceuticals, Inc.
VENDOR	VENDOR	90%	On April 15, 2026, the Company received four additional invoices from the vendor totaling $ 117,525 .
MS-PK	Morgan Stanley	72%	A will adopt this recommendation based on Dr. Thompson’s statement that data supporting the recommendation came from over 25 studies conducted all over the globe and involved more than 1,600 patients…
MS-PK	Morgan Stanley	72%	Reciprocal relationship from MS-PK graph: Reciprocal relationship from ZVSA graph: A will adopt this recommendation based on Dr. Thompson’s statement that data supporting the recommendation came from…
ORANY	ORANY	72%	lamaCORE may terminate the agreement on 10 days’ notice. Further, the agreement may be terminated by a party upon the bankruptcy or insolvency of the other party. Upon any termination of the InflamaC…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from ZVSA graph: lamaCORE may terminate the agreement on 10 days’ notice. Further, the agreement may be terminated by a party upon th…

ZyVersa Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
MS-PK	Morgan Stanley	72%	A will adopt this recommendation based on Dr. Thompson’s statement that data supporting the recommendation came from over 25 studies conducted all over the globe and involved more than 1,600 patients…
MS-PK	Morgan Stanley	72%	Reciprocal relationship from MS-PK graph: Reciprocal relationship from ZVSA graph: A will adopt this recommendation based on Dr. Thompson’s statement that data supporting the recommendation came from…
ORANY	ORANY	72%	lamaCORE may terminate the agreement on 10 days’ notice. Further, the agreement may be terminated by a party upon the bankruptcy or insolvency of the other party. Upon any termination of the InflamaC…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from ZVSA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from ZVSA graph: Reciprocal relationship from ORAN…

ZyVersa Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ZVSA-DEBT-13797	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-12.
ZVSA-DEBT-13796	Warrants outstanding: 1	90%	xbrl warrant detail from xbrl 2025-07-08.
ZVSA-DEBT	Debt stack $1.2M	90%	Market cache reports total debt of $1.2M.

ZyVersa Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ZyVersa Therapeutics, Inc..

ZyVersa Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
ZVSA-OWNER-GUERRA-ADVISORS-INC	Guerra Advisors Inc	90%	13F overlay lists Guerra Advisors Inc as top holder; 1 tracked holders.

ZyVersa Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MS-PK	Morgan Stanley	100.00	1	['customer', 'supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
CVS	CVS Health Corporation	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
AKAN	Akanda Corp.	50.00	2
D	Dominion Energy, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2

ZyVersa Therapeutics, Inc. Supply Chain